CMS Final Medicaid Drug Rebate Rule Details New Misclassification Penalties and Numerous Other Changes
FDA Law Blog
SEPTEMBER 30, 2024
Gaulkin — In May 2023, we posted about a CMS proposed regulation that sought to make a wide variety of changes to the Medicaid Drug Rebate Program (MDRP), including a new “price verification survey,” and a controversial proposal to require “stacking” of discounts to different customers when determining best price. Kirschenbaum & Sophia R.
59 
Let's personalize your content